Blood Disorder News and Research

RSS
Amgen acquires Bergamo, expands operations in Brazil

Amgen acquires Bergamo, expands operations in Brazil

Cenovus donates $1.3 million to Alberta Children's Hospital to combat childhood cancer

Cenovus donates $1.3 million to Alberta Children's Hospital to combat childhood cancer

Alexion submits Soliris marketing applications to FDA, EMA for aHUS treatment

Alexion submits Soliris marketing applications to FDA, EMA for aHUS treatment

Conflicts in medical management of hemophilia

Conflicts in medical management of hemophilia

Dentists need to take a closer look at potential hazards of exposing patients to zinc

Dentists need to take a closer look at potential hazards of exposing patients to zinc

Alexion joins EURORDIS, NORD and medical communities to observe Rare Disease Day 2011

Alexion joins EURORDIS, NORD and medical communities to observe Rare Disease Day 2011

FDA approves GSK's PROMACTA to treat rare blood disorder

FDA approves GSK's PROMACTA to treat rare blood disorder

Study: Newborn screening for hemoglobin H disease can reduce mortality rate

Study: Newborn screening for hemoglobin H disease can reduce mortality rate

SynthRx to become wholly-owned subsidiary of ADVENTRX

SynthRx to become wholly-owned subsidiary of ADVENTRX

Silent strokes can cause long-term cognitive, learning deficits in children with sickle cell disease

Silent strokes can cause long-term cognitive, learning deficits in children with sickle cell disease

Alexion fourth quarter net product sales of Soliris increases to $156.0 million

Alexion fourth quarter net product sales of Soliris increases to $156.0 million

Alexion acquires investigational therapy for MoCD Type A ultra-rare genetic disorder from Orphatec

Alexion acquires investigational therapy for MoCD Type A ultra-rare genetic disorder from Orphatec

Study finds treatment-related mortality with bevacizumab in cancer patients

Study finds treatment-related mortality with bevacizumab in cancer patients

Alexion announces acquisition of Taligen Therapeutics

Alexion announces acquisition of Taligen Therapeutics

Geron commences enrollment in imetelstat Phase 2 clinical trial in essential thrombocythemia

Geron commences enrollment in imetelstat Phase 2 clinical trial in essential thrombocythemia

Researchers report gene therapy strategy that improves Beta Thalassemia in mice model

Researchers report gene therapy strategy that improves Beta Thalassemia in mice model

First “saviour sibling” procedure successful

First “saviour sibling” procedure successful

Study reveals novel role of adenosine signaling in sickle cell disease

Study reveals novel role of adenosine signaling in sickle cell disease

Brilinta – AstraZeneca’s new blood thinner faces FDA hurdle

Brilinta – AstraZeneca’s new blood thinner faces FDA hurdle

Nose job gone horribly wrong

Nose job gone horribly wrong